2019
DOI: 10.1016/j.humpath.2018.08.038
|View full text |Cite
|
Sign up to set email alerts
|

Molecular features of pleomorphic xanthoastrocytoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 19 publications
(6 citation statements)
references
References 15 publications
0
6
0
Order By: Relevance
“…Immunohistochemistry was performed on 2.5–3.0‐μm formalin‐fixed, paraffin‐embedded (FFPE) whole‐tissue sections, as described in previous studies 13–19 . Briefly, antigens were retrieved in a pressure cooker for 2.5 min.…”
Section: Methodsmentioning
confidence: 99%
“…Immunohistochemistry was performed on 2.5–3.0‐μm formalin‐fixed, paraffin‐embedded (FFPE) whole‐tissue sections, as described in previous studies 13–19 . Briefly, antigens were retrieved in a pressure cooker for 2.5 min.…”
Section: Methodsmentioning
confidence: 99%
“…Anaplastic PXA is a rare tumor and complete specific mutation profiles have not been established. Based on targeted panel sequencing, the most frequent somatic mutations detected in PXA are BRAF, FANCA/D2/I/M, PRKDC, NF1, NOTCH2/3/4, and CDKN2A (Park et al, 2017;Zou et al, 2019). In this study, the tumors were characterized by some of these genetic alterations: BRAF, FANCD2, and CDKN2A found in all lesions.…”
Section: Discussionmentioning
confidence: 75%
“…Regarding pathogenesis, the most commonly involved pathway in their tumorigenesis is MAPK [ 3 ]. To this are added fusions of the BRAF kinase domain and/or alterations of the Pi3K/AKT/mTOR pathway [ 3 , 41 , 42 ]. In order to evaluate the aggressiveness, we evaluated the CDKN2A gene.…”
Section: Discussionmentioning
confidence: 99%